Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Towards precision prevention and early therapy for RA

Reference number
Coordinator Karolinska Institutet - Karolinska Institutet Inst f medicin Solna
Funding from Vinnova SEK 19 975 000
Project duration October 2021 - March 2025
Status Ongoing
Venture Innovation milieus in precision health
Call Innovation milieus in precision Health 2021

Purpose and goal

To change care of rheumatoid arthritis (RA), from current long-term expensive treatment towards precision prevention and early curative care. More specifically, we aim to create an ecosystem of digital, diagnostic and treatment procedures that will enable a new and personalized approach to prevention of as yet chronic diseases, beginning with RA with potentials for expansion to other diseases.

Expected effects and result

Our tools will provide a coherent system that supports not only precision prevention of RA, but also enables rapid diagnosis and very early precision therapy for those who develop arthritis despite our prevention efforts. Our systems will also enable clinical trials aimed at developing novel interventions aimed at prevention of RA.

Planned approach and implementation

We will develop and use patient-driven digital tools and new diagnostics for identification of individuals at risk for RA. The at risk individuals will be provided with digital companions enabling prevention with lifestyle changes and surveillance of therapies aimed at prevention. We will test and implement therapies aimed at personalized prevention and very early and potentially curative therapy if arthritis occurs.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 8 November 2024

Reference number 2021-02598